Literature DB >> 32948847

Barriers and facilitators for cascade testing in genetic conditions: a systematic review.

Swetha Srinivasan1, Nae Yeon Won2, W David Dotson3, Sarah T Wright4, Megan C Roberts5.   

Abstract

Cascade testing is the process of offering genetic counseling and testing to at-risk relatives of an individual who has been diagnosed with a genetic condition. It is critical for increasing the identification rates of individuals with these conditions and the uptake of appropriate preventive health services. The process of cascade testing is highly varied in clinical practice, and a comprehensive understanding of factors that hinder or enhance its implementation is necessary to improve this process. We conducted a systematic review to identify barriers and facilitators for cascade testing and searched PubMed, CINAHL via EBSCO, Web of Science, EMBASE, and the Cochrane Library for articles published from the databases' inception to November 2018. Thirty articles met inclusion criteria. Barriers and facilitators identified from these studies at the individual-level were organized into the following categories: (1) demographics, (2) knowledge, (3) attitudes, beliefs, and emotional responses of the individual, and (4) perceptions of relatives, relatives' responses, and attitudes toward relatives. At the interpersonal-level, barriers and facilitators were categorized as (1) family communication-, support- and dynamics-, and (2) provider-factors. Finally, barriers at the environmental-level relating to accessibility of genetic services were also identified. Our findings suggest that several individual, interpersonal and environmental factors may play a role in cascade testing. Future studies to further investigate these barriers and facilitators are needed to inform future interventions for improving the implementation of cascade testing for genetic conditions in clinical practice.

Year:  2020        PMID: 32948847      PMCID: PMC7784694          DOI: 10.1038/s41431-020-00725-5

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  34 in total

Review 1.  Social ecological approaches to individuals and their contexts: twenty years of health education & behavior health promotion interventions.

Authors:  Shelley D Golden; Jo Anne L Earp
Journal:  Health Educ Behav       Date:  2012-01-20

2.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  J Clin Epidemiol       Date:  2009-07-23       Impact factor: 6.437

3.  Genetic identification of familial hypercholesterolemia within a single U.S. health care system.

Authors:  Noura S Abul-Husn; Kandamurugu Manickam; Laney K Jones; Eric A Wright; Dustin N Hartzel; Claudia Gonzaga-Jauregui; Colm O'Dushlaine; Joseph B Leader; H Lester Kirchner; D'Andra M Lindbuchler; Marci L Barr; Monica A Giovanni; Marylyn D Ritchie; John D Overton; Jeffrey G Reid; Raghu P R Metpally; Amr H Wardeh; Ingrid B Borecki; George D Yancopoulos; Aris Baras; Alan R Shuldiner; Omri Gottesman; David H Ledbetter; David J Carey; Frederick E Dewey; Michael F Murray
Journal:  Science       Date:  2016-12-23       Impact factor: 47.728

4.  Genetic testing in families with hereditary nonpolyposis colon cancer.

Authors:  C Lerman; C Hughes; B J Trock; R E Myers; D Main; A Bonney; M R Abbaszadegan; A E Harty; B A Franklin; J F Lynch; H T Lynch
Journal:  JAMA       Date:  1999-05-05       Impact factor: 56.272

5.  Factors affecting encouragement of relatives among families with Lynch syndrome to seek medical assessment.

Authors:  Noriko Ishii; Masami Arai; Yurie Koyama; Masashi Ueno; Toshiharu Yamaguchi; Keiko Kazuma; Tetsuichiro Muto
Journal:  Fam Cancer       Date:  2011-12       Impact factor: 2.375

6.  Patients' perceptions and experiences of familial hypercholesterolemia, cascade genetic screening and treatment.

Authors:  Sarah J Hardcastle; Ellen Legge; Chris S Laundy; Sarah J Egan; Rosemary French; Gerald F Watts; Martin S Hagger
Journal:  Int J Behav Med       Date:  2015-02

7.  Medication adherence, cascade screening, and lifestyle patterns among women with hypercholesterolemia: Results from the WomenHeart survey.

Authors:  Gretchen Benson; Dawn R Witt; Jeffrey J VanWormer; Susan M Campbell; Arthur Sillah; Sharonne N Hayes; Matt Lui; Martha Gulati
Journal:  J Clin Lipidol       Date:  2016-03-29       Impact factor: 4.766

8.  Factors influencing uptake of familial long QT syndrome genetic testing.

Authors:  Charlotte Burns; Julie McGaughran; Andrew Davis; Christopher Semsarian; Jodie Ingles
Journal:  Am J Med Genet A       Date:  2015-11-06       Impact factor: 2.802

9.  Familial communication and cascade testing among relatives of BRCA population screening participants.

Authors:  Sari Lieberman; Amnon Lahad; Ariela Tomer; Sivan Koka; Malka BenUziyahu; Aviad Raz; Ephrat Levy-Lahad
Journal:  Genet Med       Date:  2018-03-29       Impact factor: 8.822

10.  Underdiagnosis of Hereditary Breast Cancer: Are Genetic Testing Guidelines a Tool or an Obstacle?

Authors:  Peter D Beitsch; Pat W Whitworth; Kevin Hughes; Rakesh Patel; Barry Rosen; Gia Compagnoni; Paul Baron; Rache Simmons; Linda Ann Smith; Ian Grady; Michael Kinney; Cynara Coomer; Karen Barbosa; Dennis R Holmes; Eric Brown; Linsey Gold; Patricia Clark; Lee Riley; Samuel Lyons; Antonio Ruiz; Sadia Kahn; Heather MacDonald; Lisa Curcio; Mary Kay Hardwick; Shan Yang; Ed D Esplin; Robert L Nussbaum
Journal:  J Clin Oncol       Date:  2018-12-07       Impact factor: 44.544

View more
  13 in total

1.  Genetic counselling and testing for neurodegenerative disorders using a proposed standard of practice for ALS/MND: diagnostic testing comes first.

Authors:  Ashley Crook; Alison McEwen
Journal:  Eur J Hum Genet       Date:  2022-01-05       Impact factor: 4.246

2.  Clinical Utility of Universal Germline Genetic Testing for Patients With Breast Cancer.

Authors:  Pat W Whitworth; Peter D Beitsch; Rakesh Patel; Barry Rosen; Gia Compagnoni; Paul L Baron; Rache Simmons; Eric A Brown; Linsey Gold; Dennis Holmes; Linda Ann Smith; Michael Kinney; Ian Grady; Patricia Clark; Karen Barbosa; Samuel Lyons; Lee Riley; Cynara Coomer; Lisa Curcio; Antonio Ruiz; Sadia Khan; Heather MacDonald; Kevin Hughes; Mary Kay Hardwick; Brandie Heald; Sandra B Munro; Sarah M Nielsen; Edward D Esplin
Journal:  JAMA Netw Open       Date:  2022-09-01

3.  Differences in Cancer Phenotypes Among Frequent CHEK2 Variants and Implications for Clinical Care-Checking CHEK2.

Authors:  Brittany L Bychkovsky; Nihat B Agaoglu; Carolyn Horton; Jing Zhou; Amal Yussuf; Parichehr Hemyari; Marcy E Richardson; Colin Young; Holly LaDuca; Deborah L McGuinness; Rochelle Scheib; Judy E Garber; Huma Q Rana
Journal:  JAMA Oncol       Date:  2022-09-22       Impact factor: 33.006

4.  Comparing the attitudes of physicians and non-physicians toward communicating a patient's BRCA1 mutation to a first-degree relative against a patient's wishes.

Authors:  Jane E Zebrack; Wei Yang; Matthew Milone; Max J Coppes
Journal:  J Community Genet       Date:  2022-05-21

Review 5.  Advancing Pharmacogenomics from Single-Gene to Preemptive Testing.

Authors:  Cyrine E Haidar; Kristine R Crews; James M Hoffman; Mary V Relling; Kelly E Caudle
Journal:  Annu Rev Genomics Hum Genet       Date:  2022-05-10       Impact factor: 9.340

6.  Barriers and Facilitators for Population Genetic Screening in Healthy Populations: A Systematic Review.

Authors:  Emily C Shen; Swetha Srinivasan; Lauren E Passero; Caitlin G Allen; Madison Dixon; Kimberly Foss; Brianna Halliburton; Laura V Milko; Amelia K Smit; Rebecca Carlson; Megan C Roberts
Journal:  Front Genet       Date:  2022-07-04       Impact factor: 4.772

Review 7.  Germline Aberrations in Pancreatic Cancer: Implications for Clinical Care.

Authors:  Raffaella Casolino; Vincenzo Corbo; Philip Beer; Chang-Il Hwang; Salvatore Paiella; Valentina Silvestri; Laura Ottini; Andrew V Biankin
Journal:  Cancers (Basel)       Date:  2022-06-30       Impact factor: 6.575

Review 8.  Health equity in the implementation of genomics and precision medicine: A public health imperative.

Authors:  Muin J Khoury; Scott Bowen; W David Dotson; Emily Drzymalla; Ridgely F Green; Robert Goldstein; Katherine Kolor; Leandris C Liburd; Laurence S Sperling; Rebecca Bunnell
Journal:  Genet Med       Date:  2022-04-28       Impact factor: 8.864

9.  The use of telemedicine in cardiogenetics clinical practice during the COVID-19 pandemic.

Authors:  Lusha W Liang; Isha Kalia; Farhana Latif; Marc P Waase; Yuichi J Shimada; Gabriel Sayer; Muredach P Reilly; Nir Uriel
Journal:  Mol Genet Genomic Med       Date:  2022-04-07       Impact factor: 2.473

10.  Acceptability, Appropriateness, and Feasibility of Automated Screening Approaches and Family Communication Methods for Identification of Familial Hypercholesterolemia: Stakeholder Engagement Results from the IMPACT-FH Study.

Authors:  Laney K Jones; Nicole Walters; Andrew Brangan; Catherine D Ahmed; Michael Gatusky; Gemme Campbell-Salome; Ilene G Ladd; Amanda Sheldon; Samuel S Gidding; Mary P McGowan; Alanna K Rahm; Amy C Sturm
Journal:  J Pers Med       Date:  2021-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.